Mrs. Cynthia Ramsey Moody Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 111 Ramsey Ct, Bassett, VA 24055 Phone: 276-629-5898 Fax: 276-629-5898 |
Marjorie Denise Handy, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 108 Joyce Rd, Bassett, VA 24055 Phone: 276-340-1019 |
Aleta Gibbs, RESIDENT IN COUNSELI Counselor Medicare: Not Enrolled in Medicare Practice Location: 620 County Line Rd, Bassett, VA 24055 Phone: 276-732-8111 |
News Archive
Waters Corporation reported fourth quarter 2009 sales of $429 million, an increase of 3% from sales of $418 million in the fourth quarter of 2008. In the quarter, foreign currency translation increased sales growth rate by 4% and on a currency neutral basis, sales decreased by 1% in comparison to the prior year's fourth quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.08, compared to $1.01 for the fourth quarter of 2008. On a non-GAAP basis, including the adjustments in the attached reconciliation, E.P.S. grew 5% to $1.12 from $1.07 in the fourth quarter of 2008.
Research published in the current issue of Science magazine reinforces the belief that aerobic capacity is an important determinant in the continuum between health and disease.
Now, a team of scientists in the United States plans to create a coronavirus strain that can be used for human challenge trials, a controversial type of study wherein health volunteers would be vaccinated and intentionally infected with the virus.
Middle-aged men and women with osteoarthritis of the knee now have more options than ever before for treatments that may allow them to remain active in the sports they love, according to a review published in the July 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons.
According to a statement on behalf of the American College of Medical Genetics and Genomics (ACMG) published Dec. 13 in the organization's official journal, Genetics in Medicine, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
› Verified 3 days ago